market-trends is the sole category represented across all 1 tracked stories. Celsius is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 12 original sources each against 4.5 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about GoodRx
market-trends is the sole category represented across all 1 tracked stories. Celsius is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 12 original sources each against 4.5 for the same window. At 5, the average consequence score sits below the same-window beat average of 6.9. GoodRx appears in 1 tracked Startup story from February 26, 2026.
Stories tracked
1
Sources per story
12
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 42 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering GoodRx. Shared-story counts are live from our verified record — not editorial picks.
Payoneer missed top and bottom-line estimates for Q4 2025, triggering a stock decline despite a 12% core revenue growth forecast for 2026. The company is aggressively shifting focus toward larger SMBs, stablecoin integration, and a U.S. national bank charter to solidify its cross-border payment dominance.
GoodRx is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.